Penumbra (PEN) Total Non-Current Liabilities (2014 - 2026)

Penumbra (PEN) reported Total Non-Current Liabilities of $411.4 million for Q1 2026, up 12.87% year-over-year from $364.5 million in Q1 2025, and up 6.41% quarter-over-quarter from $386.6 million in Q4 2025.

Penumbra (PEN) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Total Non-Current Liabilities data on file, last reported at $411.4 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $411.4 million, up 12.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $411.4 million (up 12.87% YoY), and the FY2025 annual result was $386.6 million, up 5.3% from the prior year.
  • Total Non-Current Liabilities improved to $411.4 million in Q1 2026 per PEN's latest filing, from $386.6 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $411.4 million in Q1 2026 and troughed at $338.7 million in Q1 2022.
  • A 5-year average of $366.8 million and a median of $365.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities surged 85.68% in 2022, then fell 1.61% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $368.8 million in 2022, then climbed by 0.9% to $372.1 million in 2023, then slipped by 1.32% to $367.1 million in 2024, then grew by 5.3% to $386.6 million in 2025, then rose by 6.41% to $411.4 million in 2026.
  • Business Quant data shows PEN's Total Non-Current Liabilities at $411.4 million in Q1 2026, $386.6 million in Q4 2025, and $371.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 20.94 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 2.44 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 24.21 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 3.53 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 3.47 Bn
10 Penumbra 12.51 Bn 11.90 Bn 253.41 Mn 411.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 411.38 Mn
Dec 31, 2025 386.60 Mn
Sep 30, 2025 371.14 Mn
Jun 30, 2025 363.04 Mn
Mar 31, 2025 364.48 Mn
Dec 31, 2024 367.14 Mn
Sep 30, 2024 365.39 Mn
Jun 30, 2024 365.71 Mn
Mar 31, 2024 370.44 Mn
Dec 31, 2023 372.05 Mn
Sep 30, 2023 360.97 Mn
Jun 30, 2023 362.70 Mn
Mar 31, 2023 367.59 Mn
Dec 31, 2022 368.75 Mn
Sep 30, 2022 344.55 Mn
Jun 30, 2022 354.41 Mn
Mar 31, 2022 338.66 Mn
Dec 31, 2021 286.77 Mn
Sep 30, 2021 281.00 Mn
Mar 31, 2021 182.39 Mn